The Antidepressant Activity of a Taurine-Containing Derivative of 4-Phenylpyrrolidone-2 in a Model of Chronic Unpredictable Mild Stress
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242316564 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Denis A Borozdenko und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy and Medicinal Chemistry, Pirogov Russian National Research Medical University, 117997 Moscow, Russia. Hauptthemen laut MEDLINE: Fluoxetine, Antidepressive Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
This study investigates the therapeutic potential of a new compound, potassium 2-[2-(2-oxo-4-phenylpyrrolidin-1-yl) acetamido]ethanesulfonate (Compound I), in depression. Willner’s chronic unpredictable mild stress model of male Wistar rats was used as a depression model. The rats were randomized into four groups, including an intact group, a Compound I group, a Fluoxetine group, and a control group with saline. Behavioral tests, such as the Porsolt forced swim test, hole-board test, elevated plus maze test, and light–dark box, were used to assess the animals’ conditions. Our results demonstrated that Compound I effectively reduced the immobilization time of rats in the forced swim test, increased orientation and exploratory behavior, and decreased the latency period of going into the dark compartment compared to the control group. Hippocampal and striatal serotonin concentrations were increased in the Compound I group, and the compound also reduced the level of corticosterone in the blood plasma of rats compared to the intact animals. These results suggest that Compound I has reliable antidepressant activity, comparable to that of the reference antidepressant Fluoxetine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacy and Medicinal Chemistry, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.
ORCID-Profile: Denis A Borozdenko, Darya I Gonchar, Yaroslav V Golubev, Nina M Kiseleva, Tatiana A Shmigol, Konstantin A Sobyanin, Vadim V Negrebetsky
Förderung
- Russian Science Foundation
Zitieren
APA
Borozdenko, D. A., Gonchar, D. I., Bogorodova, V. I., Tarasenko, D. V., Kramarova, E. P., Khovanova, S. S., Golubev, Y. V., Kiseleva, N. M., Shmigol, T. A., Ezdoglian, A. A., Sobyanin, K. A., Negrebetsky, V. V., & Baukov, Y. I. (2023). The Antidepressant Activity of a Taurine-Containing Derivative of 4-Phenylpyrrolidone-2 in a Model of Chronic Unpredictable Mild Stress. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316564
Vancouver
Borozdenko DA, Gonchar DI, Bogorodova VI, Tarasenko DV, Kramarova EP, Khovanova SS, et al. The Antidepressant Activity of a Taurine-Containing Derivative of 4-Phenylpyrrolidone-2 in a Model of Chronic Unpredictable Mild Stress. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316564
BibTeX
@article{Borozdenko2023,
author = {Borozdenko, Denis A and Gonchar, Darya I and Bogorodova, Vlada I and Tarasenko, Dmitri V and Kramarova, Evgeniya P and Khovanova, Svetlana S and Golubev, Yaroslav V and Kiseleva, Nina M and Shmigol, Tatiana A and Ezdoglian, Aiarpi A and Sobyanin, Konstantin A and Negrebetsky, Vadim V and Baukov, Yuri I},
title = {The Antidepressant Activity of a Taurine-Containing Derivative of 4-Phenylpyrrolidone-2 in a Model of Chronic Unpredictable Mild Stress},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242316564}
}
EUVIMED